Spots Global Cancer Trial Database for placebo tablet
Every month we try and update this database with for placebo tablet cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Insulin Resistance and Androgen Deprivation Therapy | NCT04995978 | Prostate Cancer Insulin Resista... | Pioglitazone 30... placebo tablet | 18 Years - 85 Years | St. Louis University | |
Reward Sensitivity and Pharmacotherapy for Smoking Cessation | NCT02162849 | Tobacco Use Ces... | Varenicline Nicotine Patch Placebo Patch Placebo Tablet Questionnaires Counseling Sess... Lab Session Saliva Test | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients | NCT03866499 | NSCLC | BPI-7711 Gefitinib Placebo Tablet Placebo capsule | 18 Years - | Beta Pharma, Inc. | |
NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers | NCT04808531 | Cancer Related ... | NanaBis™ Oxycodone CR Placebo Spray Placebo Tablet Oxycodone IR | 18 Years - 75 Years | Medlab Clinical | |
Reward Sensitivity and Pharmacotherapy for Smoking Cessation | NCT02162849 | Tobacco Use Ces... | Varenicline Nicotine Patch Placebo Patch Placebo Tablet Questionnaires Counseling Sess... Lab Session Saliva Test | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
Primary Prevention Hepatocellular Carcinoma by Metformin | NCT02319200 | Hepatocellular ... Hepatitis C, Ch... Cirrhosis | Metformin placebo tablet | 18 Years - 77 Years | Assistance Publique - Hôpitaux de Paris | |
A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer | NCT01896479 | Medullary Thyro... | Cabozantinib (X... Cabozantinib (X... Placebo tablet Placebo capsule | 18 Years - | Exelixis |